CASP3 and Hepatic fibrosis: Studies in rodents have demonstrated that apoptosis in HSCs with an along with an increase in caspase 3 activity or a reduction in Bcl-2/Bax ratio, could promote the regression of CCl4 and BDL-mediated liver fibrosis, suggesting a potential role of apoptosis of HSCs in attenuating the disease26.